Idiopathic Hypersomnia Overview
Learn About Idiopathic Hypersomnia
- Idiopathic hypersomnia
- Idiopathic hypersomnolence
- Primary hypersomnia
St Vincent Medical Education And Research Institute Inc
Jeffrey Mcgovern is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Erie, Pennsylvania. Dr. Mcgovern and is rated as an Experienced provider by MediFind in the treatment of Idiopathic Hypersomnia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, Emphysema, and Advanced Bronchoscopy.
Regional Health Services Inc
Satyasagar Morisetty is a Pulmonary Medicine specialist and a Sleep Medicine provider in Erie, Pennsylvania. Dr. Morisetty has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in the treatment of Idiopathic Hypersomnia. His top areas of expertise are Lung Metastases, Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Advanced Bronchoscopy, and Gastrostomy. Dr. Morisetty is currently accepting new patients.
Cleveland Clinic
Nancy Foldvary-Schaefer is a Sleep Medicine specialist and a Neurologist in Cleveland, Ohio. Dr. Foldvary-Schaefer and is rated as an Elite provider by MediFind in the treatment of Idiopathic Hypersomnia. Her top areas of expertise are Narcolepsy, Drowsiness, Excessive Daytime Sleepiness, and Idiopathic Hypersomnia. Dr. Foldvary-Schaefer is currently accepting new patients.
Summary: The goal of this study is to test a web-based psychoeducational resource for adolescents with central disorders of hypersomnolence and their families. The investigators hope to assess the website's usability, acceptability, and feasibility, as well as its potential effect on social relationship health. Participants will be asked to review the content of the psychoeducational websites. The particip...
Summary: This is a double-blind, placebo-controlled, randomized withdrawal, multicenter study of the efficacy and safety of FT218. FT218 drug product is a once-nightly formulation of sodium oxybate for extended-release oral suspension. The study will enroll subjects who are diagnosed with idiopathic hypersomnia. Subjects will be eligible to enroll regardless of current treatment with oxybate therapy or sti...
Published Date: May 12, 2022
Published By: Genetic and Rare Diseases Informnation Center